Bafna Pharmaceuticals Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '20
    Dec '19
    Sep '19
    Jun '19
    Sep '18
    Total Qtr Revenue cr
    12.46
    10.96
    12.16
    7.15
    8.80
    Other Income Qtr Cr-0.670.030.590.30-0.03
    Operating Revenues Qtr13.1310.9311.576.858.84

    *All values are in Cr.

    Operating Expenses Qtr
    8.89
    10.70
    11.94
    9.72
    8.65
    Operating Profit Qtr
    4.24
    0.22
    -0.38
    -2.87
    0.18
    EBITDA Qtr Cr
    2.73
    -21.46
    0.22
    -2.56
    0.15
    Depreciation Qtr
    0.52
    1.00
    0.72
    1.02
    0.75
    Net Profit Qtr
    0.32
    -22.33
    -0.59
    -2.13
    -1.28
    Basic EPS Qtr
    0.20
    -94.39
    -0.25
    -0.90
    -0.80
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -